Share on

Europe Syringes Market Research Report - Segmented By Usability, By Material, By Type & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1848
Pages: 145
Formats: report pdf report excel report power bi report ppt

Europe Syringes Market Size (2022 to 2027)      

The size of the European Syringes Market is expected to grow at a CAGR of 8% from 2022 to 2027. As a result, this market is forecasted to grow at USD 4.57 billion in 2027 from USD 3.11 billion in 2022.

The increased demand for syringes and technological developments in syringes manufacturing are majorly propelling the growth of the European syringes market. The proliferation of chronic and pandemic diseases across Europe is majorly driving the market growth; however, the increased prevalence of chronic diseases such as diabetes, infectious diseases, and cardiovascular diseases. In addition, the increasing patient population creates a demand for syringes. Private and government investments in research and development facilities are pushing market expansion even further. 

Furthermore, the market is fuelled by the increased use of prefilled syringes and injectable medications, and the industry is benefiting from an increase in demand for Botox therapeutics purposes. Furthermore, the market is helping due to the increased use of advanced technology and the introduction of numerous products that benefit end consumers. Moreover, the industry is being boosted by an increase in surgical procedures. In addition, the vaccination and immunization drive against viruses such as COVID-19, typhoid, and others will be a substantial growth opportunity for the syringes market. Furthermore, investments from the EU governments are expected to benefit the market growth during the forecast period.

The European syringes market is estimated to be hampered by the availability of alternative drug delivery techniques such as the insulin pen, which is used to inject insulin in diabetic patients. In addition, the market faces substantial obstacles, including a shortage of qualifies workers in the manufacturing area and an increase in the number of needlestick injuries.

This research report on the European syringes market has been segmented and sub-segmented into the following categories:

By Usability:

  • Sterilizable/reusable
    • Hypodermic
    • Oral
  • Disposable Syringes
    • Conventional
    • Safety
    • Prefilled

By Material:

  • Glass Syringes
  • Plastic Syringes

By Type:

  • General Syringes
  • Specialized Syringes
    • Insulin
    • Tuberculin
    • Allergy
    • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the European syringes market held a promising share in the global market in 2020 and is majorly driven by the availability of improved technology in medical testing facilities and government programs that provide funding.  In addition, most syringes and needles in Europe are sold individually and then combined as needed. However, there are some special markets, such as Italy, where strong sales of pre-attached syringes and needles make the stand-alone market modest in comparison.

The UK syringes market was the largest regional market in Europe, and it is expected to remain so throughout the projected period.

Germany is known for developing and mass-producing innovative new syringes. As a result, Germany is the world’s largest syringe exporter, accounting for 8.69 percent of syringes sent to industrialized countries. In the German syringe market, B. Braun, Melungen AG, Schott AG, and Gerresheimer AG have the majority of the market share.

In terms of healthcare infrastructure and the pharmaceutical industry, Russia is the fastest-growing country. For insulin syringes, Russia has the most significant market share. Diabetic patients are becoming more common in the country, which is fueling the market expansion. Insulin syringes and shipments are imported into Russia. However, the market’s growth is being hampered by Russia’s low costs and strict restrictions for local syringe exchange. By focusing on drug injectors, pharmacy-based syringe distribution and exchange will assist enhance the cost-effectiveness of HIV prevention.


A few of the prominent companies operating in the European syringes market profiled in this report are Terumo Corporation, B. Braun Medical Inc., Medtronic plc, Becton, Dickinson and Company, Smiths Medical, NIPRO Corporation, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, SCHOTT AG, and CODAN Medizinische Geräte GmbH & Co KG.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample